Kroin David
SEC-identified person · CIK 1397513 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Dynavax Technologies Corp dvax | Officer | filed 2024 - 2026 |
| LB Pharmaceuticals INC LBRX | Officer | filed 2025 - 2026 |
| Nektar Therapeutics NKTR | Officer | filed 2024 - 2024 |
| Foamix Pharmaceuticals Ltd. FOMX | Officer | filed 2017 - 2018 |
| Adamas Pharmaceuticals Inc ADMS | Officer | filed 2016 - 2017 |
| Connecture INC CNXR | Officer | filed 2014 - 2015 |
| Infusystem Holdings, Inc infu | Officer | filed 2007 - 2011 |
| Biodel Inc BIODEL | Director | filed 2007 - 2010 |
| Memory Pharmaceuticals Corp MEMY | Officer | filed 2007 - 2009 |
| Medecision, Inc. MEDE | Officer | filed 2008 - 2008 |
| Caprius INC CAPS.OB | Officer | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.